CLEW Expands Its Intelligent Clinical Surveillance Platform to All Inpatient Settings
April 29 2024 - 8:30AM
Business Wire
The FDA-cleared system is proven to accurately
predict patient deterioration, reduce caregiver burden and create
opportunities for early intervention in critical care settings
CLEW, a clinical intelligence and predictive surveillance
company, today announced the general availability of its
FDA-cleared, AI-driven, intelligent clinical surveillance platform.
Built upon proprietary, machine-learning derived prediction models
and rules-based best practices, the CLEW platform offers health
systems an early identification of a patient’s risk of
deterioration.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240429304093/en/
(Photo: CLEW)
CLEW initially introduced its system of AI-generated prediction
models in 2019 to support critical care and telemedicine
operations, aiming to enhance patient care in virtual intensive
care units (VICUs or Tele-ICUs). Implemented in numerous critical
care departments across the United States, including Penn State
Health, the system quickly demonstrated its efficacy and CLEW
promptly responded to customer demands by expanding its platform to
areas such as the emergency department, medical/surgical floors,
perioperative suites, and specialty care units.
"As we navigate the complexities of modern healthcare,
AI-derived systems emerge as a beacon of innovation, transforming
our approach to care delivery,” Paul Roscoe, CLEW CEO shared. “When
delivered with meticulous regulatory oversight, AI can unlock new
possibilities for precision medicine, early detection, and
personalized treatments. Our commitment to integrating AI-driven
prediction models into healthcare reflects our dedication to
enhancing patient outcomes, driving efficiencies, and ultimately,
saving lives."
Equipped with these advanced clinical insights, caregivers can
focus on delivering exceptional patient care at the highest level
of their licensure. The CLEW system empowers care teams to
intervene proactively in identifying high-risk patients up to eight
hours before physiological signs and other monitoring systems would
indicate. This leads to lower mortality rates, decreased
complications, and fewer readmissions. As a result, proactive and
timely care mitigates unforeseen bottlenecks, reduces length of
stay and improves overall capacity.
In addition to CLEW’s robust prediction models, its platform
includes built-in, best practice clinical protocols. They are
easily customizable, allowing health systems to add their own
standard practices for consistent deployment of specific care
plans. With its NotifyMe solution, caregivers can receive tailored
multi-parameter smart alerts, specifically designed to pinpoint
urgent and complex clinical scenarios. Clinicians have the
flexibility to determine which attributes and clinical criteria are
crucial for monitoring and personalize the configuration.
The CLEW platform also includes prediction-driven
clinician-centric tools designed to reduce nursing fatigue,
including a real-time, priority-driven patient worklist developed
in collaboration with nurses at Penn State Health. Since going live
with the platform, the critical care team at Penn State has
integrated the use of CLEW into their daily workflow.
A recent peer-reviewed study published in CHEST Journal, notably
found that predictions from the CLEW platform were at least five
times more accurate than alerts from the leading telemedicine
system and generated 50 times fewer alarms than other monitoring
systems. For more information about that study, click here.
For more information about the CLEW system, contact the CLEW
team.
About CLEW Medical, Inc. CLEW offers the first
FDA-cleared, class II medical device, AI-based clinical predictive
models for critical care as a part of its intelligent clinical
surveillance platform. Its ability to offer accurate, predictive
insights around patient deterioration allows health systems to
optimize patient interventions, decreasing mortality and reducing
complications & readmissions. Its proprietary models offer an
optimal balance of precision and sensitivity, which results in
fewer high-risk notifications, reducing alarm fatigue amongst
providers and clinicians. For more information, visit
clewmed.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240429304093/en/
Media Matter Health for CLEW Medical Matt Robbins T:
617.874.5203 clew@matternow.com